|
Real-time Estimate
Cboe Europe
06:19:19 23/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,894.00 GBX | -1.04% |
|
+1.77% | +3.89% |
| 22/10 | UK's FTSE 100 falls as banks, miners drag; Barclays slides on job cuts | RE |
| 22/10 | UNICEF and Gavi agree to cut Mosquirix malaria vaccine price by 40% | RE |
Company Valuation: GSK plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,458 | 58,381 | 59,112 | 54,944 | 73,201 | 76,694 | - | - |
| Change | - | -27.44% | 1.25% | -7.05% | 33.23% | 4.77% | - | - |
| Enterprise Value (EV) 1 | 1,00,296 | 75,578 | 74,152 | 68,039 | 87,654 | 97,870 | 94,988 | 92,161 |
| Change | - | -24.65% | -1.89% | -8.24% | 28.83% | 11.65% | -2.94% | -2.98% |
| P/E | 18.6x | 3.93x | 11.9x | 21.3x | 12.9x | 14.5x | 12.2x | 11.4x |
| PBR | 5.34x | 5.47x | 4.4x | 4.02x | 4.51x | 4.82x | 4.24x | 3.66x |
| PEG | - | 0x | -0.2x | -0.4x | 0x | -2.33x | 0.7x | 1.6x |
| Capitalization / Revenue | 2.36x | 1.99x | 1.95x | 1.75x | 2.24x | 2.26x | 2.16x | 2.09x |
| EV / Revenue | 2.94x | 2.58x | 2.45x | 2.17x | 2.68x | 2.89x | 2.68x | 2.51x |
| EV / EBITDA | 8.85x | 7.23x | 6.37x | 6.36x | 7.77x | 8.45x | 7.73x | 7.3x |
| EV / EBIT | 11.4x | 9.27x | 8.44x | 7.44x | 8.96x | 9.45x | 8.56x | 7.95x |
| EV / FCF | 22.6x | 12.1x | 13.6x | 13x | 13.7x | 18.7x | 17.8x | 14.3x |
| FCF Yield | 4.42% | 8.28% | 7.36% | 7.67% | 7.32% | 5.36% | 5.61% | 6.98% |
| Dividend per Share 2 | 1 | 0.6125 | 0.58 | 0.61 | 0.66 | 0.6945 | 0.7471 | 0.7819 |
| Rate of return | 4.98% | 4.26% | 4% | 4.53% | 3.62% | 3.63% | 3.9% | 4.09% |
| EPS 2 | 1.082 | 3.662 | 1.216 | 0.632 | 1.411 | 1.323 | 1.57 | 1.683 |
| Distribution rate | 92.4% | 16.7% | 47.7% | 96.5% | 46.8% | 52.5% | 47.6% | 46.5% |
| Net sales 1 | 34,114 | 29,324 | 30,328 | 31,376 | 32,667 | 33,904 | 35,509 | 36,682 |
| EBITDA 1 | 11,330 | 10,449 | 11,635 | 10,693 | 11,278 | 11,582 | 12,281 | 12,629 |
| EBIT 1 | 8,806 | 8,151 | 8,786 | 9,148 | 9,783 | 10,352 | 11,101 | 11,595 |
| Net income 1 | 4,385 | 14,956 | 4,928 | 2,575 | 5,716 | 5,356 | 6,225 | 6,686 |
| Net Debt 1 | 19,838 | 17,197 | 15,040 | 13,095 | 14,453 | 21,176 | 18,294 | 15,467 |
| Reference price 2 | 20.08 | 14.38 | 14.50 | 13.46 | 18.24 | 19.14 | 19.14 | 19.14 |
| Nbr of stocks (in thousands) | 40,06,383 | 40,60,999 | 40,76,145 | 40,80,519 | 40,12,126 | 40,07,011 | - | - |
| Announcement Date | 09/02/22 | 01/02/23 | 31/01/24 | 05/02/25 | 04/02/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14.47x | 2.89x | 8.45x | 3.63% | 10TCr | |
| 37.7x | 13.43x | 28.51x | 0.52% | 1,16500Cr | |
| 39.17x | 6.59x | 18.54x | 1.99% | 64TCr | |
| 36.4x | 8.37x | 17.27x | 2.41% | 50TCr | |
| 20.97x | 5.15x | 12.78x | 2.55% | 38TCr | |
| 107.33x | 5.99x | 25.72x | 2.31% | 36TCr | |
| 21.95x | 5.71x | 14.04x | 2.79% | 30TCr | |
| 22.67x | 4.58x | 13.09x | 1.93% | 27TCr | |
| 28.38x | 7.14x | 12.79x | 2.26% | 24TCr | |
| -45.82x | 7.02x | 27.23x | 2.1% | 19TCr | |
| Average | 28.32x | 6.69x | 17.84x | 2.25% | 41.58TCr | |
| Weighted average by Cap. | 35.21x | 8.31x | 20.43x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GSK Stock
- Valuation GSK plc
Select your edition
All financial news and data tailored to specific country editions
